Improving the Treatment of Schizophrenia: Role of 5-HT Receptors in Modulating Cognitive and Extrapyramidal Motor Functions
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
12
Page:
861-869
Author(s):
Saki Shimizu, Yuto Mizuguchi and Yukihiro Ohno
Neuropeptide Systems and Schizophrenia
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
12
Page:
619-632
Author(s):
Amber L. LaCrosse and M. Foster Olive
From Preclinical to Clinical Trials: An Update on Potential Therapies for Huntington’s Disease
Journal:
Current Psychopharmacology
Volume:
2
Page:
113-131
Author(s):
Patricia S. Brocardo and Joana M. Gil-Mohapel
Antipsychotic Polypharmacy: Still Dirty, But Hardly a Secret. A Systematic Review and Clinical Guide
Journal:
Current Psychopharmacology
Volume:
2
Page:
143-171
Author(s):
Derek K. Tracy, Kyra-Verena Sendt and Sukhwinder S. Shergill
Pediatric Catatonia: Updating An Old Syndrome in Young People
Journal:
Current Psychiatry Reviews
Volume:
9
Page:
120-129
Author(s):
Dirk Dhossche, Lee E. Wachtel, Edward Shorter and Neera Ghaziuddin
An Outline of the Historical and Clinical Aspects of Catatonic Schizophrenia
Journal:
Current Psychiatry Reviews
Volume:
9
Page:
94-100
Author(s):
Gabor S. Ungvari, Stephan C. Mann and Stanley N. Caroff
D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
2499-2511
Author(s):
Silvia Sacchi, Elena Rosini, Loredano Pollegioni and Gianluca Molla
History and Therapeutic Use of MAO-A Inhibitors: A Historical Perspective of MAO-A Inhibitors As Antidepressant Drug
Journal:
Current Topics in Medicinal Chemistry
Volume:
12
Page:
2275-2282
Author(s):
Matilde Yanez, Juan Fernando Padin, Juan Alberto Arranz-Tagarro, Mercedes Camina and Reyes Laguna
Olanzapine Loaded Cationic Solid Lipid Nanoparticles for Improved Oral Bioavailability
Journal:
Current Nanoscience
Volume:
9
Page:
26-34
Author(s):
Sumeet Sood, Natarajan Jawahar, Kunal Jain, Kuppusamy Gowthamarajan and Subramania Nainar Meyyanathan
Restless Legs Syndrome in Multiple Sclerosis
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
11
Page:
1061-1069
Author(s):
Chiara Zecca, Mauro Manconi, Stephany Fulda and Claudio Gobbi